Loading...
Loading...
Of the 20 tracked institutions holding CVS, 13 have a 3-year clone track record — 9 of them beat the S&P. Average holder's clone alpha: +2.9pt. It's a gauge of who owns the name, not just how many.
Among the 20 tracked institutional investors we monitor, CVS (CVS HEALTH CORP) is held with a combined value of $30.86B across 417,040,130 shares. The largest holder is VANGUARD GROUP INC with a position worth $9.58B (0.14% of their portfolio). 3 funds opened new positions in the most recent quarter. 7 funds increased their holdings. 10 funds reduced their position.
Total Institutional Value
$30.86B
Total Shares Held
417,040,130
Institutional Holders
20
% of Shares Outstanding
32.7%
of 1.28B shares · SEC 2026-04-29
Days to Cover
2.7-2.1%
19.52M shares short · FINRA 2026-07-15
Tracked 13F institutions hold 32.7% of CVS's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2026-04-29), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $9.58B | 0.14% | +1.5% |
| 2 | BlackRock, Inc. | $9.04B | 0.16% | +4.1% |
| 3 | STATE STREET CORP | $4.26B | 0.15% | -1.4% |
| 4 | FMR LLC | $2.24B | 0.12% | -23.9% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | $1.71B | 0.20% | +44.6% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | $1.62B | 0.30% | +21.6% |
| 7 | Capital Research Global Investors | $1.44B | 0.22% | +66.2% |
| 8 | CITADEL ADVISORS LLC | $389.84M | 0.28% | +50.7% |
| 9 | AQR CAPITAL MANAGEMENT LLC | $169.64M | 0.08% | -8.7% |
| 10 | MILLENNIUM MANAGEMENT LLC | $126.80M | 0.05% | -57.4% |
| Member | Type | Date |
|---|---|---|
| Alan Armstrong | Buy | Mar 27, 2026 |
| John Boozman | Buy | Jan 29, 2026 |
| Dwight Evans | Sell | Nov 21, 2025 |
| Lisa McClain | Sell |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CVS with a position worth $9.58B, representing 0.14% of their portfolio. In total, 20 institutional investors hold CVS with a combined value of $30.86B.
In the most recent quarter, 3 funds opened a new position in CVS. Additionally, 7 increased their holdings and 10 reduced their positions.
Institutional investors hold $30.86B worth of CVS stock across 20 positions. The largest institutional holder is VANGUARD GROUP INC with $9.58B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CVS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CVS positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Oct 31, 2025 |
| Lisa McClain | Buy | Oct 30, 2025 |
| Lisa McClain | Sell | Oct 30, 2025 |
| Adam Smith | Sell | Aug 8, 2025 |
| Rob Bresnahan | Sell | May 15, 2025 |
Showing 8 of 57. STOCK Act disclosures lag up to 45 days.
Last Close
$107.87
2026-07-27
YTD
+37.8%
96% of 52-week range
